American Gene Technologies International Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:American Gene Technologies International Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10630
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
American Gene Technologies International Inc (AGT) is a drug development company that tests and commercializes gene-based drugs. The company develops therapies for the treatment of cancer, neurological disorders, AIDS, infectious diseases, Parkinson’s diseases, diabetes, familial dysautonomia, hepatocellular carcinoma, phenylketonuria, autosomal disorders, and other chronic human diseases. It also provides rapid drug development programs, genetic technologies and gamma delta T cell therapy, among others. AGT develops various products in the laboratory testing phase for oncology indications. The company partners with medical researchers, and pharmaceutical and biotech firms for its drug development activities. AGT is headquartered in Rockville, Maryland, the US.

American Gene Technologies International Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
American Gene Technologies International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
American Gene Technologies Raises USD1.2 Million in Venture Financing 10
American Gene Technologies Raises USD0.3 Million in Venture Financing 11
American Gene Technologies Raises USD1.3 Million in Venture Financing 12
Partnerships 13
GeoVax Labs Enters into Partnership with American Gene Technologies 13
American Gene Technologies Partners with University of Pittsburgh 14
American Gene Technologies International Inc – Key Competitors 15
American Gene Technologies International Inc – Key Employees 16
American Gene Technologies International Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Sep 11, 2017: American Gene Technologies Appoints Julia R. Brown to its Board of Directors 18
Apr 12, 2017: American Gene Technologies Announces C. Neil Lyons as Chief Financial Officer 19
Product News 20
10/12/2017: American Gene Technologies Inc. (AGT) Demonstrates Rationale of its Genetic Approach toward developing a Functional Cure for HIV Infection 20
Clinical Trials 21
Jan 25, 2018: American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Key Facts 2
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
American Gene Technologies International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
American Gene Technologies International Inc, Deals By Therapy Area, 2012 to YTD 2018 8
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
American Gene Technologies Raises USD1.2 Million in Venture Financing 10
American Gene Technologies Raises USD0.3 Million in Venture Financing 11
American Gene Technologies Raises USD1.3 Million in Venture Financing 12
GeoVax Labs Enters into Partnership with American Gene Technologies 13
American Gene Technologies Partners with University of Pittsburgh 14
American Gene Technologies International Inc, Key Competitors 15
American Gene Technologies International Inc, Key Employees 16

List of Figures
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
American Gene Technologies International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[American Gene Technologies International Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Morphotek Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Morphotek Inc (Morphotek), a subsidiary of Eisai Inc, is a clinical-stage biotechnology company that develops monoclonal antibodies, antibody drug conjugates, and bispecific antibodies to treat cancer, inflammatory and infectious diseases. Its pipeline product portfolio includes farletuzumab …
  • Macquarie Telecom Group Limited (MAQ):企業の財務・戦略的SWOT分析
    Macquarie Telecom Group Limited (MAQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • United Food Holdings Limited:戦略・SWOT・企業財務分析
    United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Great Portland Estates Plc (GPOR):企業の財務・戦略的SWOT分析
    Great Portland Estates Plc (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Quantum Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Quantum Energy Inc (Quantum Energy), formerly MJD Solutions Inc is an oil and gas company. The company operates in refinery development, land holdings, oil and natural gas exploration, drilling, well completion, and fuel distribution in the Bakken field. Its products lines include ngl’s, gas …
  • SoftwareONE Holding AG (SWON):企業の財務・戦略的SWOT分析
    SoftwareONE Holding AG (SWON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Walgreens Boots Alliance, Inc.:企業の戦略・SWOT・財務情報
    Walgreens Boots Alliance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Walgreens Boots Alliance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Hess Corp (HES):石油・ガス:M&Aディール及び事業提携情報
    Summary Hess Corp (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, the Joint Development Area of Malaysia/Thailand (JDA), and Malaysia. It offers fee-based services including gathering, …
  • Galp Energia SGPS SA (GALP):企業の財務・戦略的SWOT分析
    Galp Energia SGPS SA (GALP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Slanchev den AD Varna:企業の戦略・SWOT・財務情報
    Slanchev den AD Varna - Strategy, SWOT and Corporate Finance Report Summary Slanchev den AD Varna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Plantronics, Inc. (PLT):企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Mitsubishi Research Institute Inc (3636):企業の財務・戦略的SWOT分析
    Mitsubishi Research Institute Inc (3636) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Hengeler Mueller Partnerschaft von Rechtsanwalten mbB:企業の戦略的SWOT分析
    Hengeler Mueller Partnerschaft von Rechtsanwalten mbB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key com …
  • High Plains Power Inc:企業の戦略的SWOT分析
    High Plains Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • CSE Global Ltd (544):石油・ガス:M&Aディール及び事業提携情報
    Summary CSE Global Limited (CSE) is a technology company offering process control systems and integrated plant communication systems. It’s process control systems offers emergency shutdown systems, process shutdown systems, integrated control & safety systems and fire and gas detection systems, well …
  • Natcore Technology Inc (NXT):企業の財務・戦略的SWOT分析
    Summary Natcore Technology Inc (Natcore) is a solar research and development company that provides products for semiconductor and fiber optic applications. The company’s products include solar cell structures and black silicon cells. It uses liquid phase deposition technology for controlling deposit …
  • Seelos Therapeutics, Inc. (SEEL):企業の財務・戦略的SWOT分析
    Seelos Therapeutics, Inc. (SEEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • China National Petroleum Corporation (CNPC):戦略・SWOT・企業財務分析
    China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report Summary China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Elron Electronic Industries Ltd (ELRNF):医療機器:M&Aディール及び事業提携情報
    Summary Elron Electronic Industries Ltd (Elron), a subsidiary of IDB Holding Corp Ltd, is a provider of medical device and cyber technology solutions. The company offers development of patient care systems for stroke care, microbiology, age-related macular degeneration, orthopedics, and heart diseas …
  • Simulations Plus Inc (SLP)-医療機器分野:企業M&A・提携分析
    Summary Simulations Plus Inc (Simulations Plus) develops and markets software for drug discovery and development for the pharmaceutical and biotechnology industries. The company develops absorption, distribution, metabolism, excretion and toxicity modeling and simulation software. It provides precli …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆